Page last updated: 2024-12-08

alpha-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

alpha-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11743251
MeSH IDM0059559

Synonyms (16)

Synonym
alpha-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol
2-piperidinemethanol, alpha-(3,6-bis(trifluoromethyl)-9-phenanthrenyl)-
rti1164-1-1
(-)-erythro-[3,6-bis(trifluoromethyl)-phenanthren-9-yl]-piperidin-2-yl-methanol
(s)-[3,6-bis(trifluoromethyl)-9-phenanthryl]-[(2r)-2-piperidyl]methanol
34484-89-4
unii-7p13170f5s
7p13170f5s ,
wr-122455 free base
wr 122455 free base
wr-122,455 free base
2-piperidinemethanol, .alpha.-(3,6-bis(trifluoromethyl)-9-phenanthrenyl)-
.alpha.-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol
DTXSID70188041
Q27268657
fvvwtczwvduhph-uxhiceinsa-n
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]